Treatment for Pre-symptomatic Spinal Muscular Atrophy Patients Granted FDA Priority Review
source: pixabay.com

Treatment for Pre-symptomatic Spinal Muscular Atrophy Patients Granted FDA Priority Review

PTC Therapeutics Inc. has just announced that their supplemental new drug application for Evrysdi (risdiplam) has been given priority review by the FDA. The aim is to expand the indication…

Continue Reading Treatment for Pre-symptomatic Spinal Muscular Atrophy Patients Granted FDA Priority Review
Grandma Raises Spinal Muscular Atrophy Awareness After Grandson’s Death
https://pixabay.com/en/baby-small-little-cute-newborn-2453297/

Grandma Raises Spinal Muscular Atrophy Awareness After Grandson’s Death

When Rhonda Stevey met her grandson, Koehyn, she was immediately smitten. The grandmother, who lives in Ohio, felt like her grandson was the happiest infant she had ever met. Unfortunately,…

Continue Reading Grandma Raises Spinal Muscular Atrophy Awareness After Grandson’s Death
Singapore: 29,000 Donors Responded to a Plea By Devdan’s Parents For a One Time Gene Therapy Treatment That Costs $2.8 Million
source: pixabay.com

Singapore: 29,000 Donors Responded to a Plea By Devdan’s Parents For a One Time Gene Therapy Treatment That Costs $2.8 Million

According to YAHOO News, twenty-two-month-old Devdan has a rare disease called type 2 spinal muscular atrophy (SMA2) which affects nerve cells that control muscles. If left untreated progressive muscle weakness…

Continue Reading Singapore: 29,000 Donors Responded to a Plea By Devdan’s Parents For a One Time Gene Therapy Treatment That Costs $2.8 Million
Evrysdi (risdiplam) Shows Promising Results in Tiniest Spinal Muscular Atrophy Patients
source: pixabay.com

Evrysdi (risdiplam) Shows Promising Results in Tiniest Spinal Muscular Atrophy Patients

by Lauren Taylor from In The Cloud Copy Spinal muscular atrophy or SMA is a disease that affects the patient’s central nervous system, peripheral nervous system, and skeletal muscles or…

Continue Reading Evrysdi (risdiplam) Shows Promising Results in Tiniest Spinal Muscular Atrophy Patients